Page last updated: 2024-08-26

s-nitrosoglutathione and Coronary Disease

s-nitrosoglutathione has been researched along with Coronary Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, AS; de Belder, AJ; Langford, EJ; Martin, JF; Moncada, S; Radomski, MW; Smith, RE; Thomas, MR; Wainwright, RJ	1
de Belder, AJ; Langford, EJ; Marrinan, MT; Martin, JF; Moncada, S; Salas, E	1
Campanella, C; Megson, IL; Sogo, N; Webb, DJ	1

Trials

2 trial(s) available for s-nitrosoglutathione and Coronary Disease

Article	Year
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet (London, England), 1994, Nov-26, Volume: 344, Issue:8935 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Female; Glutathione; Heparin; Humans; Male; Middle Aged; Nitroglycerin; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recurrence; S-Nitrosoglutathione	1994
S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. Heart (British Cardiac Society), 1998, Volume: 80, Issue:2 Topics: Aged; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Female; Glutathione; Graft Occlusion, Vascular; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardial Revascularization; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein	1998

Article

Year

Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.

Lancet (London, England), 1994, Nov-26, Volume: 344, Issue:8935

Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Female; Glutathione; Heparin; Humans; Male; Middle Aged; Nitroglycerin; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recurrence; S-Nitrosoglutathione

1994

S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo.

Heart (British Cardiac Society), 1998, Volume: 80, Issue:2

Topics: Aged; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Female; Glutathione; Graft Occlusion, Vascular; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardial Revascularization; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein

1998

Other Studies

1 other study(ies) available for s-nitrosoglutathione and Coronary Disease

Article	Year
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. British journal of pharmacology, 2000, Volume: 131, Issue:6 Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; Mammary Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroso Compounds; Penicillamine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein; Vasodilation; Vasodilator Agents	2000

Article

Year

S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.

British journal of pharmacology, 2000, Volume: 131, Issue:6

Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; Mammary Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroso Compounds; Penicillamine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein; Vasodilation; Vasodilator Agents

2000